Alpha-S1-casein (CSN1S1, 214 AA, ~27 kDa), member of casein family of milk proteins. Phosphoprotein that forms calcium-phosphate-rich micelles in milk enabling efficient delivery of minerals and protein to nursing infant. Intrinsically disordered protein with multiple phosphoserine clusters that bind calcium ions and sequester calcium phosphate nanoclusters in colloidal micelles. Self-associates and interacts with other caseins (alpha-S2, beta, kappa) via hydrophobic/electrostatic interactions forming large micellar aggregates. Plays important role in capacity of milk to transport calcium phosphate. Expression tightly linked to lactation cycle - minimally expressed in non-lactating conditions but robustly induced during late pregnancy/lactation by prolactin via JAK2-STAT5 pathway in mammary alveolar epithelial cells. Synthesized in rough ER, phosphorylated in Golgi, packaged into secretory vesicles and secreted into mammary gland alveoli lumen. Present at very low levels in human milk (trace amounts, <1% of milk protein) compared to cow's milk. Beyond nutrition, generates bioactive peptides upon proteolysis - casoxin D (opioid receptor antagonist with vasorelaxant activity). Recent research reveals immunomodulatory role: unphosphorylated alpha-S1-casein adopts helical conformation enabling TLR4 binding on immune cells, triggering pro-inflammatory cytokine release. Phosphorylation acts as molecular toggle shifting from immune-stimulatory form (less phosphorylated, α-helical) to nutritional form (phosphorylated, disordered). Most milk alpha-S1-casein highly phosphorylated (optimized for calcium transport). Can influence monocyte differentiation toward macrophage phenotype and suppress dendritic cell differentiation. Major allergen in cow's milk allergy. Ectopic expression outside mammary gland observed in autoimmune/inflammatory diseases and some cancers.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Extracellular space - in milk extracellularly.
Reason: Specific extracellular location.
Supporting Evidence:
file:human/CSN1S1/CSN1S1-deep-research-openai.md
See deep research file for comprehensive analysis
file:human/CSN1S1/CSN1S1-deep-research-falcon.md
For CSN1S1/αS1-casein, the functional location is primarily **extracellular in milk**, where it participates in micelle formation
|
|
GO:0032355
response to estradiol
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: CSN1S1 gene expression is regulated by estradiol during mammary gland development and lactation. Estrogen is critical for mammary epithelial cell proliferation and differentiation.
Reason: Reflects transcriptional regulation of CSN1S1 during mammary development rather than a direct molecular function of the protein itself. Hormone response at gene expression level is upstream of protein function.
|
|
GO:0032570
response to progesterone
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: CSN1S1 gene expression is regulated by progesterone during mammary gland development. Progesterone prepares mammary tissue for milk production during pregnancy.
Reason: Reflects transcriptional regulation during mammary development rather than direct protein function. Appropriate IBA annotation but not a core molecular activity.
|
|
GO:1903494
response to dehydroepiandrosterone
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: DHEA is an androgen precursor with potential effects on mammary tissue. Less direct connection to CSN1S1 than estrogen/progesterone.
Reason: Phylogenetically inferred annotation. May reflect species-specific hormonal regulation of milk protein genes. Not a core function of the mature CSN1S1 protein.
|
|
GO:1903496
response to 11-deoxycorticosterone
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: 11-deoxycorticosterone is a glucocorticoid precursor. Glucocorticoids do participate in regulation of milk protein gene expression during lactation.
Reason: Phylogenetically inferred annotation reflecting hormonal regulation of milk protein genes. Glucocorticoids modulate lactation but this is upstream transcriptional regulation, not protein function.
|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Extracellular region - secreted into milk.
Reason: Core localization.
Supporting Evidence:
file:human/CSN1S1/CSN1S1-deep-research-falcon.md
Caseins are **synthesized in the mammary gland** and proceed through the **endoplasmic reticulum and Golgi** where they undergo post-translational modifications; they are then **secreted into milk as colloidal micelles**
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
REMOVE |
Summary: Generic protein binding from HuRI interactome study. CSN1S1 self-associates and interacts with other caseins to form micelles.
Reason: Uninformative generic term per curation guidelines. The biologically relevant interactions are casein self-association and inter-casein binding to form micellar structures, but "protein binding" does not capture this specificity. The HuRI study is a high-throughput screen without functional context.
Supporting Evidence:
PMID:32296183
Apr 8. A reference map of the human binary protein interactome.
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-5340124 |
ACCEPT |
Summary: Extracellular region - secreted into milk.
Reason: Core localization.
Supporting Evidence:
file:human/CSN1S1/CSN1S1-deep-research-falcon.md
Caseins are **synthesized in the mammary gland** and proceed through the **endoplasmic reticulum and Golgi** where they undergo post-translational modifications; they are then **secreted into milk as colloidal micelles**
|
|
GO:0005509
calcium ion binding
|
NAS | NEW |
Summary: alpha-S1-casein binds Ca2+ ions through clusters of phosphoserine residues in its hydrophilic phosphopeptide region, enabling formation of calcium-phosphate-stabilized casein micelles in milk.
Reason: Core molecular function of caseins. Phosphoserine-clustered Ca2+ binding is what allows alpha-S1/alpha-S2/beta-caseins to coordinate colloidal calcium phosphate inside micelles and deliver bioavailable mineral nutrition to the nursing infant.
Supporting Evidence:
file:human/CSN1S1/CSN1S1-uniprot.txt
Major milk phosphoprotein that binds calcium ions via phosphoserine clusters, forming calcium-phosphate-rich micelles for efficient mineral and protein delivery to nursing infant. Also has immunomodul...
file:human/CSN1S1/CSN1S1-deep-research-falcon.md
αS1-, αS2-, and β-caseins are calcium-binding phosphoproteins located mainly in the micelle interior, associating with colloidal calcium phosphate
|
|
GO:0007595
lactation
|
NAS | NEW |
Summary: alpha-S1-casein is a major secreted milk-specific phosphoprotein synthesized by mammary epithelial cells under prolactin/glucocorticoid control and secreted into milk during lactation, where it co-assembles with other caseins into colloidal micelles.
Reason: Lactation captures the developmental/physiological process in which CSN1S1 carries out its function; secretion into milk is the gene's defining biological context.
Supporting Evidence:
file:human/CSN1S1/CSN1S1-uniprot.txt
Major milk phosphoprotein that binds calcium ions via phosphoserine clusters, forming calcium-phosphate-rich micelles for efficient mineral and protein delivery to nursing infant. Also has immunomodul...
file:human/CSN1S1/CSN1S1-deep-research-falcon.md
Caseins are **synthesized in the mammary gland** and proceed through the **endoplasmic reticulum and Golgi** where they undergo post-translational modifications; they are then **secreted into milk as colloidal micelles**
|
|
GO:0140314
calcium ion sequestering activity
|
NAS | NEW |
Summary: Alpha-S1-casein binds Ca2+ via clusters of phosphoserine residues and traps it as colloidal calcium phosphate (CCP) inside casein micelle interiors, removing free Ca2+ from the available pool and stabilizing otherwise supersaturating calcium-phosphate concentrations in milk for delivery to the nursing infant.
Reason: GO:0140314 (calcium ion sequestering activity, defined as binding to a calcium ion
to prevent it from interacting with other partners or to inhibit its localization)
accurately captures the casein function. The previously proposed GO:0006816
(calcium ion transport) is inappropriate -- caseins are secreted structural
phosphoproteins, not transporters or pores. Replaces a previously proposed
GO:0006816 NEW annotation per PR #678 review feedback.
Supporting Evidence:
file:human/CSN1S1/CSN1S1-uniprot.txt
Major milk phosphoprotein that binds calcium ions via phosphoserine clusters, forming calcium-phosphate-rich micelles for efficient mineral and protein delivery to nursing infant.
file:human/CSN1S1/CSN1S1-deep-research-falcon.md
caseins assemble with **colloidal calcium phosphate** into casein micelles; αS1-, αS2-, and β-caseins are emphasized as **calcium-binding** and located mainly in the micelle interior
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The target protein is human αS1-casein, encoded by CSN1S1. In the accessible literature retrieved here, CSN1S1 is explicitly identified as the gene encoding αS1-casein within the canonical mammalian casein gene cluster (CSN1S1, CSN2, CSN1S2, CSN3) (Runthala et al., 2023; DOI: https://doi.org/10.3390/molecules28052023) (runthala2023caseinsversatilityof pages 2-4). This matches the UniProt description you provided (αS1-casein precursor; alpha-casein family).
However, the retrieved full texts did not explicitly mention UniProt accession P47710 or the specific InterPro IDs you listed; thus, accession-level cross-verification cannot be shown from within the retrieved corpus, and the identity verification is therefore at the gene/protein name + biological context level (human milk casein fraction) rather than via direct UniProt text evidence (runthala2023caseinsversatilityof pages 2-4).
Caseins are a set of milk phosphoproteins whose major biological role is nutrient and mineral (notably calcium) delivery from mammary gland secretion to the nursing infant, achieved through assembly into casein micelles with colloidal calcium phosphate (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4). Caseins are described as having open/flexible conformations, and their post-translational modifications (notably phosphorylation of α- and β-caseins; glycosylation of κ-casein) are important for micelle stability and function (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4).
In this literature set, CSN1S1 encodes αS1-casein (runthala2023caseinsversatilityof pages 2-4). Functionally, αS1-casein is part of the “calcium-sensitive” caseins; together with β-casein (and where present αS2-casein), it contributes to the micelle interior and participates in calcium phosphate association (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4).
Caseins are synthesized in the mammary gland and proceed through the endoplasmic reticulum and Golgi where they undergo post-translational modifications; they are then secreted into milk as colloidal micelles that reside in the alveolar lumen after secretion (runthala2023caseinsversatilityof pages 2-4, runthala2023caseinsversatilityof pages 4-7).
For CSN1S1/αS1-casein, the functional location is primarily extracellular in milk, where it participates in micelle formation and thereby influences nutritional delivery and physicochemical behavior of milk (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4).
A 2023 review summarizes that caseins assemble with colloidal calcium phosphate into casein micelles; αS1-, αS2-, and β-caseins are emphasized as calcium-binding and located mainly in the micelle interior, while κ-casein forms a stabilizing surface layer (“brush”) (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4). On this basis, the primary functional annotation for human αS1-casein is as a minor structural/nutritional micellar casein.
A key quantitative result compiled in the 2023 review is that human milk total casein concentration is ~2.4–4.2 g/L, and within this, αS1-casein is a minor fraction (~3% of casein) (relative ratio αS1:β:κ ≈ 3:70:27), while αS2-casein is reported as absent (“-”) in that comparison table (runthala2023caseinsversatilityof pages 2-4). The same source reports a mean human casein micelle diameter of 64–80 nm (runthala2023caseinsversatilityof pages 2-4). These statistics are directly relevant to annotation, because they support that CSN1S1 is expressed and secreted into milk but at low abundance relative to β- and κ-casein in humans.
Beyond structural/nutritional roles, proteolysis of milk proteins can produce bioactive peptides.
Casoxin D is specifically documented as a peptide derived from human αS1-casein. An EFSA scientific report (2009) lists Casoxin D as originating from human αS1-casein fragment 158–164, with sequence YVPFPPF, and states that casoxins behave as opioid antagonists (publication year: 2009; DOI: https://doi.org/10.2903/j.efsa.2009.231r) (noni2009reviewofthe pages 15-17).
A later synthesis chapter (Haq, 2020; DOI: https://doi.org/10.1007/978-981-15-6102-3) reiterates Casoxin D’s sequence and describes casoxins as opioid antagonists with receptor selectivity discussion; it also situates casoxins as peptides that can be generated by proteolysis/digestion and summarizes reported immunological assay readouts (PBMC proliferation/cytokines) associated with casoxin D in cited work and in patent contexts (haq2020opioidfoodpeptides pages 83-85, haq2020opioidfoodpeptides pages 21-23).
Functional implication: for CSN1S1, a plausible second-level functional annotation is as a precursor of specific digestion-/proteolysis-derived peptides (e.g., Casoxin D) with reported opioid-receptor antagonist activity (noni2009reviewofthe pages 15-17, haq2020opioidfoodpeptides pages 21-23).
The most directly relevant 2023–2024 obtainable full-text source found here is a 2023 review focused on caseins and micellar organization, providing human-specific quantitative composition (casein g/L, αS1 proportion) and micelle size (runthala2023caseinsversatilityof pages 2-4). It also emphasizes that micellar architecture, post-translational modifications, and casein composition underpin key functional properties (digestibility, coagulation, processing) (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4).
Search results indicated a potentially highly relevant 2024 primary paper on structural analysis of breast-milk αs1-casein and TLR4 stimulation (International Journal of Molecular Sciences, 2024; DOI: 10.3390/ijms25031743), but the full text was not obtainable with the current toolchain in this run. Because it could not be accessed, it is not used as evidence for any claim here.
A 2023 review connects casein micelle organization and composition to functional/nutritional and industrial properties of milk, including stomach coagulation, digestibility, and dairy processing outcomes such as cheese and yogurt manufacture (Runthala et al., 2023; published Feb 2023; DOI: https://doi.org/10.3390/molecules28052023) (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4). Because αS1-casein is part of the micellar system (albeit minor in human milk), these principles provide the most evidence-supported route to “applications” relevant to CSN1S1.
The EFSA report frames casoxin D (from human αS1-casein) within the broader set of food-derived opioid receptor ligands and specifically states that casoxins are opioid antagonists (2009; DOI: https://doi.org/10.2903/j.efsa.2009.231r) (noni2009reviewofthe pages 15-17, noni2009reviewofthe pages 11-15). The 2020 chapter discusses therapeutic/patent-oriented perspectives and describes physiological and immunological process modulation as a conceptual application area for such peptides (2020; DOI: https://doi.org/10.1007/978-981-15-6102-3) (haq2020opioidfoodpeptides pages 83-85, haq2020opioidfoodpeptides pages 21-23).
A key authoritative synthesis is the 2023 Molecules review, which emphasizes that casein post-translational modifications and micellar organization are central to both nutritional and processing properties, and explicitly notes that differences between species can be leveraged to develop “functionally improved casein molecules with variable biological and industrial utilities” (runthala2023caseinsversatilityof pages 1-2). The EFSA 2009 scientific review provides an authoritative regulatory-science perspective on opioid-peptide precursors in foods, and it explicitly maps Casoxin D to human αS1-casein and classifies casoxins as opioid antagonists (noni2009reviewofthe pages 15-17, noni2009reviewofthe pages 11-15).
The following table consolidates the most directly supported functional annotation points and quantitative values.
| Category | Evidence-based details | Key source (author, year, DOI URL) |
|---|---|---|
| Gene/protein identity | CSN1S1 is identified as the gene encoding αS1-casein within the mammalian casein gene cluster (CSN1S1, CSN2, CSN1S2, CSN3) on chromosome 6; in human milk, αS1-casein is present at low abundance relative to other caseins. (runthala2023caseinsversatilityof pages 2-4) | Runthala et al., 2023, https://doi.org/10.3390/molecules28052023 |
| Expression/localization | Caseins are synthesized in the mammary gland, processed through the ER/Golgi with post-translational modification, and secreted into milk as colloidal micelles; caseins reside in the alveolar lumen after secretion. (runthala2023caseinsversatilityof pages 2-4, runthala2023caseinsversatilityof pages 4-7) | Runthala et al., 2023, https://doi.org/10.3390/molecules28052023 |
| Role in micelles | αS1-, αS2-, and β-caseins are calcium-binding phosphoproteins located mainly in the micelle interior, associating with colloidal calcium phosphate; κ-casein stabilizes the micelle surface. For humans, low αS-casein content suggests αS1 plays a comparatively minor but still canonical micellar role. (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4) | Runthala et al., 2023, https://doi.org/10.3390/molecules28052023 |
| Quantitative abundance in human milk | Human milk total casein concentration is reported as 2.4–4.2 g/L. Relative casein composition is approximately αS1 3%, αS2 absent, β 70%, κ 27% (ratio 3:70:27). Mean human casein micelle diameter is 64–80 nm. (runthala2023caseinsversatilityof pages 2-4) | Runthala et al., 2023, https://doi.org/10.3390/molecules28052023 |
| Bioactive peptide Casoxin D | Human Casoxin D is derived from αS1-casein fragment 158–164 with sequence YVPFPPF. Reviews classify casoxins as opioid antagonists; a 2020 synthesis reports receptor selectivity for MOP or DOP and notes digestion/proteolysis as a source of such peptides, with additional PBMC immunomodulatory assay effects described. (noni2009reviewofthe pages 15-17, haq2020opioidfoodpeptides pages 21-23, haq2020opioidfoodpeptides pages 83-85) | EFSA review, 2009, https://doi.org/10.2903/j.efsa.2009.231r; Haq, 2020, https://doi.org/10.1007/978-981-15-6102-3 |
| Applications/implications | Casein composition and micelle organization influence dairy functionality (e.g., cheese/yogurt processing), stomach coagulation, digestibility, and allergenicity. Reviews also discuss exploiting casein structural differences to develop improved nutritional/industrial casein ingredients; casoxin D has been discussed as a therapeutic concept/patented opioid-antagonist peptide, but direct recent human CSN1S1 implementation evidence is limited. (runthala2023caseinsversatilityof pages 1-2, runthala2023caseinsversatilityof pages 2-4, haq2020opioidfoodpeptides pages 83-85) | Runthala et al., 2023, https://doi.org/10.3390/molecules28052023; Haq, 2020, https://doi.org/10.1007/978-981-15-6102-3 |
Table: This table compiles the core evidence-based functional annotation for human CSN1S1/alpha-S1-casein, including localization, micelle role, abundance, and the derived peptide casoxin D. It is useful as a concise reference for the main supported claims and their source provenance.
References
(runthala2023caseinsversatilityof pages 2-4): Ashish Runthala, Mustapha Mbye, Mutamed M. Ayyash, Yajun Xu, and A. Kamal-Eldin. Caseins: versatility of their micellar organization in relation to the functional and nutritional properties of milk. Molecules, 28:2023, Feb 2023. URL: https://doi.org/10.3390/molecules28052023, doi:10.3390/molecules28052023. This article has 101 citations.
(runthala2023caseinsversatilityof pages 1-2): Ashish Runthala, Mustapha Mbye, Mutamed M. Ayyash, Yajun Xu, and A. Kamal-Eldin. Caseins: versatility of their micellar organization in relation to the functional and nutritional properties of milk. Molecules, 28:2023, Feb 2023. URL: https://doi.org/10.3390/molecules28052023, doi:10.3390/molecules28052023. This article has 101 citations.
(runthala2023caseinsversatilityof pages 4-7): Ashish Runthala, Mustapha Mbye, Mutamed M. Ayyash, Yajun Xu, and A. Kamal-Eldin. Caseins: versatility of their micellar organization in relation to the functional and nutritional properties of milk. Molecules, 28:2023, Feb 2023. URL: https://doi.org/10.3390/molecules28052023, doi:10.3390/molecules28052023. This article has 101 citations.
(noni2009reviewofthe pages 15-17): Review of the potential health impact of β-casomorphins and related peptides 1 This article has 163 citations.
(haq2020opioidfoodpeptides pages 83-85): Mohammad Raies Ul Haq. Opioid food peptides: significant exorphins from food sources. Opioid Food Peptides, Jan 2020. URL: https://doi.org/10.1007/978-981-15-6102-3, doi:10.1007/978-981-15-6102-3. This article has 5 citations.
(haq2020opioidfoodpeptides pages 21-23): Mohammad Raies Ul Haq. Opioid food peptides: significant exorphins from food sources. Opioid Food Peptides, Jan 2020. URL: https://doi.org/10.1007/978-981-15-6102-3, doi:10.1007/978-981-15-6102-3. This article has 5 citations.
(noni2009reviewofthe pages 11-15): Review of the potential health impact of β-casomorphins and related peptides 1 This article has 163 citations.
CSN1S1, also known as alpha-S1-casein, is a protein-coding gene that belongs to the casein family of milk proteins (www.genecards.org). Caseins are the major protein constituents of milk in mammals; in dairy species like cattle they account for ~80% of milk protein and form large calcium–phosphate complexes called micelles (pmc.ncbi.nlm.nih.gov). The CSN1S1 gene encodes the alpha-S1-casein polypeptide (UniProt ID P47710), which in humans is 214 amino acids (∼27 kDa) and is part of a cluster of casein genes (including CSN1S2, CSN2, CSN3) co-localized on chromosome 4q13 (pmc.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). Notably, alpha-S1-casein is abundant in cow’s milk but is present only at very low levels in human milk (trace amounts, less than 1% of total milk protein) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Despite its low abundance in humans, alpha-S1-casein is an important component of the milk protein matrix, with specialized functions in nutrient delivery and potential regulatory roles.
The primary function of alpha-S1-casein is nutritional and structural, enabling milk to efficiently deliver calcium and phosphate to the nursing infant (www.genecards.org). Casein proteins like alpha-S1-casein are phosphoproteins that bind calcium ions and sequester calcium phosphate nanoclusters, assembling into large colloidal micelles in milk (pmc.ncbi.nlm.nih.gov). This micellar structure allows milk to remain liquid while carrying high concentrations of calcium and inorganic phosphate, which are essential for neonatal bone development (pmc.ncbi.nlm.nih.gov). In fact, alpha-S1-casein plays an “important role in the capacity of milk to transport calcium phosphate,” according to UniProt (www.genecards.org). Within the micelle, alpha-S1-casein interacts with other caseins (alpha-S2, beta, and kappa casein) – for example, it forms heteromultimers with kappa-casein that help stabilize the micelle structure (www.genecards.org). These casein complexes serve as a nutrient reservoir, rich in amino acids and minerals, that is delivered to the offspring during lactation. Experimental studies have shown that removing or altering alpha-casein can impact milk composition; in goats, for instance, knockdown of CSN1S1 reduced alpha-S1-casein content and concomitantly increased beta-casein levels, improving the milk’s digestibility and lowering its allergenic potential (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Thus, alpha-S1-casein is a key structural protein that ensures efficient nutrition, although its relative abundance and exact makeup differ between species.
Beyond its role in nutrient transport, alpha-S1-casein can give rise to biologically active peptides upon proteolysis. Digestive enzymes in the infant’s gastrointestinal tract or during food processing can cleave caseins to release peptides with diverse bioactivities (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). One notable example is “Casoxin D,” a peptide derived from alpha-S1-casein, which acts as an opioid receptor antagonist and exhibits vasorelaxant activity via bradykinin B1 receptors (www.genecards.org). This contrasts with other casein-derived peptides like beta-casomorphins that are opioid agonists. Such bioactive fragments suggest that, in addition to its nutritional value, alpha-S1-casein’s sequence encodes regulatory peptides that may affect the infant’s physiology (e.g. analgesic, antihypertensive, or immunomodulatory effects (pmc.ncbi.nlm.nih.gov)). Indeed, there is commercial interest in these peptides: a tryptic hydrolysate of alpha-S1-casein (often derived from bovine milk and marketed as “Lactium”) has been studied as a nutraceutical for stress relief and sleep improvement (pubmed.ncbi.nlm.nih.gov). In a recent randomized trial (2024), supplementation with this alpha-S1-casein hydrolysate significantly improved sleep quality and reduced sleep onset latency in adults with chronic insomnia (pubmed.ncbi.nlm.nih.gov), highlighting a real-world application of an alpha-S1-casein–derived product.
Alpha-S1-casein is characterized by a highly dynamic, flexible structure typical of casein proteins. It is largely intrinsically disordered, lacking a fixed tertiary structure in solution, which facilitates its assembly into micelles and binding of minerals (pmc.ncbi.nlm.nih.gov). The protein contains multiple phosphoserine clusters (sites of serine phosphorylation), and these negatively charged phosphate groups are critical for binding calcium ions and insoluble calcium phosphate in milk (pmc.ncbi.nlm.nih.gov). Proper phosphorylation is essential for casein functionality – studies in other mammals demonstrate that phosphorylation at specific serine residues is required for stable micelle formation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In bovine alpha-S1-casein, 8–9 serine residues are phosphorylated; the human alpha-S1-casein is also phosphorylated, though it exists in only trace amounts in human milk and was identified later than other human caseins (pmc.ncbi.nlm.nih.gov). This post-translational modification is carried out by casein kinase(s) in the mammary gland and effectively “charges” the casein, enabling it to cluster with colloidal calcium phosphate.
Within the milk, alpha-S1-casein self-associates and also binds to other caseins (alpha-S2, beta, kappa) via hydrophobic and electrostatic interactions (pmc.ncbi.nlm.nih.gov). Kappa-casein (CSN3) in particular acts as a hydrophilic “cap” on casein micelles, interacting with alpha- and beta-caseins and keeping the micelle suspended in solution. The casein micelle has a complex, branching structure, but can be envisioned as a roughly spherical aggregate of several thousand casein molecules and calcium phosphate nanoclusters (pmc.ncbi.nlm.nih.gov). The intrinsically disordered nature of alpha-S1-casein is thought to be important for this assembly; it can expose flexible regions to bind minerals and other proteins, and even exhibits molecular “chaperone-like” activity by stabilizing other proteins in the crowded milieu of milk (pmc.ncbi.nlm.nih.gov). Bovine alpha-S1-casein has been intensively studied in terms of its secondary structure and self-interactions (pmc.ncbi.nlm.nih.gov). By circular dichroism, it shows some alpha-helical segments, but these can fluctuate; overall the protein does not fold into a rigid shape. This structural adaptability underlies the dual nature of alpha-S1-casein: on one hand, an amorphous aggregating protein ideal for nutrient delivery, and on the other hand, a protein that can adopt specific conformations under certain conditions (as discussed below) to perform regulatory roles.
Emerging research indicates that human alpha-S1-casein may adopt distinct conformations that modulate its biological activity. A recent 2024 structural study found that purified human alpha-S1-casein can assume a helical conformation which enables it to bind Toll-like receptor 4 (TLR4) on immune cells (pmc.ncbi.nlm.nih.gov). Interestingly, this TLR4-agonist form was associated specifically with the unphosphorylated state of the protein (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In vitro, unphosphorylated human alpha-S1-casein (rich in α-helix) could trigger TLR4 signaling and induce secretion of pro-inflammatory cytokines (such as IL-8) from immune cells (pmc.ncbi.nlm.nih.gov). However, when the casein was phosphorylated (either naturally or via protein kinase CK2 in the experiment), its helical content dropped and it no longer activated TLR4 (pmc.ncbi.nlm.nih.gov). These results suggest a conformational switch mechanism: alpha-S1-casein can exist in two functionally distinct forms – an immune-stimulatory form (less phosphorylated, more α-helical) and a nutritional form (phosphorylated, disordered) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Phosphorylation thus acts as a molecular toggle that shifts alpha-S1-casein from a potential signaling molecule to a purely structural/nutrient role (pmc.ncbi.nlm.nih.gov). In practical terms, most alpha-S1-casein in milk is highly phosphorylated (optimized for calcium transport), so the immunomodulatory conformation may be latent under normal conditions. Nonetheless, this finding highlights that alpha-S1-casein’s structure–function relationship is nuanced, and that the protein’s traditional role in nutrition might be augmented by a regulatory capacity when its post-translational state or environment changes.
Expression of CSN1S1 is tightly linked to the lactation cycle and primarily restricted to the mammary glands. Under non-lactating conditions, the gene is minimally expressed, but during late pregnancy and lactation, hormonal signals (especially prolactin) induce robust transcription of CSN1S1 in mammary alveolar epithelial cells (pmc.ncbi.nlm.nih.gov). The casein genes, including CSN1S1, lie in a conserved cluster and are coordinately upregulated by lactogenic hormones to produce the high levels of milk protein needed postpartum (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Prolactin activates the JAK2–STAT5 signaling pathway in mammary cells, and STAT5 is a pivotal transcription factor for casein gene promoters (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Experimental evidence in bovine cells shows that constitutively active STAT5A can cause an explosive increase in alpha-casein mRNA expression (over 10^5-fold induction of CSN1S1 transcripts) (pubmed.ncbi.nlm.nih.gov). Consistently, the promoters of the alpha-S1-casein genes contain STAT5 binding sites, and STAT5 binding has been confirmed to drive their transcription (pubmed.ncbi.nlm.nih.gov). These data underscore that CSN1S1 is part of the core lactogenic gene program, directly controlled by prolactin/STAT5 signaling. Other hormones such as glucocorticoids and insulin also synergize to maximize milk protein expression, and tissue-specific factors (like mammary gland-specific enhancers and the extracellular matrix context) further regulate the CSN1S1 gene (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Once transcribed and translated, the alpha-S1-casein protein includes a signal peptide that targets it to the secretory pathway (pmc.ncbi.nlm.nih.gov). It is synthesized in the rough endoplasmic reticulum of mammary epithelial cells, heavily phosphorylated in the Golgi, and then packaged into secretory vesicles. Together with other caseins and lactose, it is secreted into the lumen of the mammary gland alveoli, where it concentrations and forms micelles in the milk before being excreted through the nipple. Thus, the subcellular localization of alpha-S1-casein is in the secretory pathway inside the cell, and ultimately in the extracellular space (in milk) outside the cell (www.genecards.org).
Under normal physiology, alpha-casein’s function is extracellular (within milk), and it is not present at significant levels in other tissues. However, some intriguing studies have detected ectopic expression of CSN1S1 in contexts outside lactation. For example, gene expression profiling found alpha-S1-casein upregulated in certain disease states: it has been reported as over-expressed in the lymph nodes of mice with experimental autoimmune encephalomyelitis (EAE) and in the blood of patients with multiple sclerosis (bmcimmunol.biomedcentral.com). Independent studies also noted elevated CSN1S1 expression in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis (bmcimmunol.biomedcentral.com), and even in some prostate and breast tumor tissues (pmc.ncbi.nlm.nih.gov). These findings suggest that CSN1S1 expression can be aberrantly induced outside the mammary gland, possibly during inflammation or cancer. The source of this ectopic alpha-casein (and whether it is produced by immune cells or by cells undergoing pathological change) remains unclear. One hypothesis is that inflammatory cytokines or certain differentiation signals might activate a dormant regulatory element of the casein gene cluster in non-mammary cells (bmcimmunol.biomedcentral.com). Alternatively, the presence of alpha-casein peptides in the circulation could come from dietary or microbiome sources. While the phenomenon is not fully understood, the immunological studies described below indicate that alpha-S1-casein can influence immune cells directly – raising the possibility that when present in the bloodstream or tissues, it might modulate immune responses.
Historically, caseins were viewed as purely nutritional proteins, but recent research reveals immunomodulatory roles for alpha-S1-casein. In vitro studies have demonstrated that human alpha-S1-casein can act on white blood cells and affect their behavior. A 2013 study showed that adding recombinant human CSN1S1 to primary monocytes skewed their differentiation toward a macrophage-like phenotype (bmcimmunol.biomedcentral.com) (bmcimmunol.biomedcentral.com). Monocytes exposed to alpha-S1-casein exhibited morphological changes (developing pseudopodia and aggregating) and upregulated macrophage markers CD14 and CD64, similar to what is seen with colony-stimulating factor (M-CSF) plus IFN-γ treatment (bmcimmunol.biomedcentral.com). Their phagocytic activity also increased, and conversely, alpha-casein suppressed the differentiation of monocytes into dendritic cells (inhibiting the effects of GM-CSF/IL-4) (bmcimmunol.biomedcentral.com). This indicates that alpha-S1-casein has proinflammatory and immune-directing capacity, biasing immune cells toward a phagocytic, inflammatory macrophage profile. Mechanistically, the study found that the ERK1/2 MAP kinase pathway was required for the monocyte differentiation effect (its inhibition blocked CD14 upregulation), and that alpha-casein stimulation led to secretion of cytokines like interleukin-1β and IL-6, which was sensitive to JNK/p38 MAPK inhibitors (bmcimmunol.biomedcentral.com). The authors concluded that “functions of CSN1S1 are beyond nutritional properties and include immunomodulatory effects,” emphasizing a broader role for this milk protein (bmcimmunol.biomedcentral.com).
At the molecular level, as noted earlier, unphosphorylated alpha-S1-casein can engage Toll-like receptor 4 (TLR4) on immune cells (pmc.ncbi.nlm.nih.gov). TLR4 is a pattern-recognition receptor of the innate immune system (famously activated by bacterial LPS) and its stimulation leads to production of proinflammatory cytokines. Experiments have shown that human alpha-S1-casein, in a specific conformation, can directly trigger TLR4-dependent cytokine release (including TNF-α, IL-1β, IL-8 and GM-CSF) (pmc.ncbi.nlm.nih.gov). This activity was abolished when the casein was phosphorylated, suggesting that alpha-S1-casein might function as a conditional danger signal – potentially helping to prime the infant’s immune system during breastfeeding, or contributing to inflammatory conditions if misregulated (pmc.ncbi.nlm.nih.gov). Interestingly, there is evidence that exposure to alpha-casein in infancy can induce a long-lasting immune memory: one study noted that breastfeeding can lead to a lifelong IgG antibody response against alpha-S1-casein in humans (pmc.ncbi.nlm.nih.gov). This implies that the protein (or its peptides) are immunogenic, and early-life exposure may tolerance-train or conversely sensitize the immune system. In some cases, alpha-casein acts as an allergen: indeed, alpha-S1-casein (particularly from cow’s milk) is a major milk allergen associated with infant cow-milk allergy (pubmed.ncbi.nlm.nih.gov). Human infants allergic to cow’s milk often react to alpha-S1-casein, and efforts have been made to breed goats or cows with lower CSN1S1 expression to produce hypoallergenic milk (pubmed.ncbi.nlm.nih.gov). This underscores that while alpha-S1-casein can have beneficial immunological interactions (e.g. maturing gut immunity), it can also provoke allergic responses in susceptible individuals.
In terms of signaling pathways, alpha-S1-casein’s mode of action on immune cells appears to involve pattern-recognition and cytokine pathways rather than classical ligand–receptor signaling. The TLR4 pathway identified for unphosphorylated alpha-casein suggests a role in innate immune activation (pmc.ncbi.nlm.nih.gov). On the flipside, within the mammary gland, alpha-S1-casein itself has been implicated in signaling feedback that regulates milk composition. A 2020 study in goat mammary cells found that alpha-S1-casein can negatively regulate the JAK2–STAT5 pathway: overexpression of CSN1S1 reduced JAK2/STAT5 phosphorylation and led to lower beta-casein (CSN2) expression, whereas knocking down CSN1S1 had the opposite effect (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). These results suggest a potential feedback mechanism where accumulating alpha-casein dampens prolactin/STAT5 signaling to modulate the relative production of milk proteins (pubmed.ncbi.nlm.nih.gov). Although this was shown in goat cells, it provides a hint that alpha-S1-casein (or a fragment of it) might interact with signaling molecules inside the mammary cell, adding a layer of autoregulation to milk protein synthesis. In summary, CSN1S1 is involved in multiple pathways: extracellularly it participates in innate immune receptor signaling (TLR4) and cell differentiation signals, and intracellularly it may interface with key lactogenic signaling (STAT5) through feedback inhibition. Each of these roles is context-dependent, emphasizing that alpha-S1-casein’s function extends beyond simple nutrition into immunological and regulatory domains when conditions permit.
Although alpha-S1-casein’s principal role is in normal human biology (i.e. infant nutrition during nursing), understanding this protein has practical implications in medicine, nutrition, and biotechnology. In neonates, casein’s ability to form a curd in the stomach slows protein digestion, providing a sustained release of amino acids – a trait exploited in infant formula design. The relatively low level of alpha-S1-casein in human breast milk (with human milk being richer in whey proteins and beta-casein) is thought to make human milk more easily digestible than cow’s milk for infants (pmc.ncbi.nlm.nih.gov). Conversely, cow’s milk, high in alpha-S1-casein, can be harder for infants to digest and is a common trigger of milk allergy. Milk allergies in infants are often linked to an immune response against caseins, and alpha-S1-casein in cow’s milk is recognized as a particularly allergenic component (pubmed.ncbi.nlm.nih.gov). Some hypoallergenic infant formulas use extensively hydrolyzed casein (breaking it into small peptides) to avoid triggering this immune response. Intriguingly, as noted, those peptides can retain useful bioactivities without causing full allergic reactions. For example, hydrolysates of bovine alpha-S1-casein have anxiolytic effects (e.g. the decapeptide alpha-casozepine in the product Lactium) and are being used or investigated as natural therapeutics for stress, insomnia, and mild anxiety (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). This illustrates how bioactive fragments of a milk protein have been translated into a real-world intervention for adults, beyond their original context in infant nutrition.
In biotechnology, the CSN1S1 gene and its regulatory elements are leveraged for high-level expression of recombinant proteins in the milk of transgenic animals. Because casein genes are among the most highly expressed genes during lactation (producing grams per liter of protein in milk), researchers have inserted therapeutic protein genes under the control of the alpha-casein promoter to create “milk bioreactors” (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For instance, the strong promoter and locus control region of CSN1S1 have been used in mice, goats, and cows to drive the production of pharmaceuticals (like hormones, growth factors, or antibodies) in milk (pmc.ncbi.nlm.nih.gov). The rationale is that the mammary gland can secrete large quantities of protein, and using a casein locus ensures the transgene is expressed only during lactation and mainly in milk, minimizing systemic effects on the host animal. A recent study in 2022 tested CRISPR/Cas9 knock-in of a human gene into the mouse Csn1s1 locus, finding that homozygous replacement of the alpha-casein gene yielded high transgene expression and did not adversely affect the health of the animals (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This suggests that while alpha-S1-casein is important for milk nutrition, its absence can be tolerated by the mother if the offspring’s dietary needs are otherwise met (in lab conditions, pups can survive on supplemented feed or the remaining milk proteins). Such studies pave the way for producing “humanized” milk or pharmaceutically augmented milk. On the flip side, breeding programs in dairy animals sometimes aim to modulate CSN1S1 expression to alter milk properties. For example, certain goat breeds carry a variant of CSN1S1 resulting in very low alpha-S1-casein in their milk; this milk is naturally easier to digest and less allergenic for humans, making it attractive for specialty dairy products (pubmed.ncbi.nlm.nih.gov). Understanding the genetic variants of CSN1S1 and their effect on milk composition is therefore valuable for the dairy industry, as it directly influences cheese yield, milk allergenicity, and nutritional profile (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov).
In summary, the human CSN1S1 (alpha-S1-casein) gene encodes a multifunctional milk protein that is central to lactation’s nutritional strategy. Its primary role is to form calcium-phosphate–rich micelles in milk, enabling efficient delivery of minerals and protein to the infant (www.genecards.org) (pmc.ncbi.nlm.nih.gov). It carries out this role extracellularly in the milk, after being secreted by mammary epithelial cells during lactation. At the biochemical level, alpha-S1-casein exemplifies an intrinsically disordered phosphoprotein optimized for colloidal assembly and nutrient binding. However, modern research has illuminated additional facets of its function: alpha-S1-casein can influence immune pathways and cell signaling, acting as a context-dependent signaling molecule when not in its fully phosphorylated, micelle-bound state (pmc.ncbi.nlm.nih.gov) (bmcimmunol.biomedcentral.com). Authoritative studies in the last decade have shifted the perspective of alpha-casein from a passive nutrient to a protein with “beyond nutritional” properties (bmcimmunol.biomedcentral.com). For instance, Dr. J. Rijnkels and colleagues have highlighted the casein gene cluster as a model for hormone-responsive gene regulation, reflecting its critical role in the developmental biology of the mammary gland (pmc.ncbi.nlm.nih.gov). Immunologists have similarly pointed out the possible immunomodulatory influence of milk caseins on the infant gut and immune development (bmcimmunol.biomedcentral.com) (pmc.ncbi.nlm.nih.gov). It is now postulated that alpha-S1-casein has dual functionality – a nutritive role when phosphorylated and incorporated into milk micelles, and a potential immunostimulatory role when unphosphorylated or presented to the immune system in a certain form (pmc.ncbi.nlm.nih.gov).
From an evolutionary standpoint, the casein proteins (including alpha-S1) are a key innovation of mammals, balancing the demands of nutrition and immune protection for offspring (pmc.ncbi.nlm.nih.gov). The conservation of the CSN1S1 gene across mammals (with species-specific variations in expression level and peptide sequence) underscores its importance in neonatal diet. Yet the low abundance of alpha-S1-casein in human milk compared to other species highlights how different mammals have tuned the casein blend for their particular needs (pmc.ncbi.nlm.nih.gov). Human milk, being relatively alpha-S1-casein-poor and beta-casein-rich, may reflect an adaptation toward easier digestion and lower allergenicity, while still maintaining sufficient calcium transport capacity via the casein micelles (pmc.ncbi.nlm.nih.gov). This fine-tuning is a subject of ongoing research, as scientists seek to improve infant formulas to more closely mimic human milk composition (pubmed.ncbi.nlm.nih.gov).
In conclusion, CSN1S1’s gene product alpha-S1-casein is primarily a milk protein that serves a structural/nutritional role in calcium transport, but it also participates in biological processes such as immune modulation and possibly feedback regulation of milk synthesis. It functions predominately in the extracellular compartment (the milk lumen) and is a component of the lactation biochemical pathway, strongly regulated by prolactin and STAT5 signaling (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). While broad systemic effects of alpha-S1-casein are limited under normal conditions, its precise role in milk is central to infant nutrition, and its secondary roles (e.g. generation of bioactive peptides, TLR4 activation) provide intriguing examples of how milk components can influence physiology. Ongoing studies and expert reviews continue to refine our understanding of this protein, reaffirming that what was once considered a simple nutrient carrier is, in fact, a versatile molecule at the interface of nutrition and immunity (bmcimmunol.biomedcentral.com) (pmc.ncbi.nlm.nih.gov).
Sources: Recent literature and reviews were used to compile this information, including primary research articles (2013–2024) on alpha-S1-casein’s structure and function (pmc.ncbi.nlm.nih.gov) (bmcimmunol.biomedcentral.com), as well as authoritative databases (UniProt, GeneCards) and comparative studies of milk protein biology (www.genecards.org) (pmc.ncbi.nlm.nih.gov). These sources provide experimental evidence for the functions and interactions described, ensuring that each claim is supported by current scientific data (publication years 2020–2024 for latest findings, with classic studies cited for foundational concepts). All key points are referenced to specific studies or reviews, and the publication dates/links are provided where available in the reference brackets.
id: P47710
gene_symbol: CSN1S1
product_type: PROTEIN
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: 'Alpha-S1-casein (CSN1S1, 214 AA, ~27 kDa), member of casein family of
milk proteins. Phosphoprotein that forms calcium-phosphate-rich micelles in milk
enabling efficient delivery of minerals and protein to nursing infant. Intrinsically
disordered protein with multiple phosphoserine clusters that bind calcium ions and
sequester calcium phosphate nanoclusters in colloidal micelles. Self-associates
and interacts with other caseins (alpha-S2, beta, kappa) via hydrophobic/electrostatic
interactions forming large micellar aggregates. Plays important role in capacity
of milk to transport calcium phosphate. Expression tightly linked to lactation cycle
- minimally expressed in non-lactating conditions but robustly induced during late
pregnancy/lactation by prolactin via JAK2-STAT5 pathway in mammary alveolar epithelial
cells. Synthesized in rough ER, phosphorylated in Golgi, packaged into secretory
vesicles and secreted into mammary gland alveoli lumen. Present at very low levels
in human milk (trace amounts, <1% of milk protein) compared to cow''s milk. Beyond
nutrition, generates bioactive peptides upon proteolysis - casoxin D (opioid receptor
antagonist with vasorelaxant activity). Recent research reveals immunomodulatory
role: unphosphorylated alpha-S1-casein adopts helical conformation enabling TLR4
binding on immune cells, triggering pro-inflammatory cytokine release. Phosphorylation
acts as molecular toggle shifting from immune-stimulatory form (less phosphorylated,
α-helical) to nutritional form (phosphorylated, disordered). Most milk alpha-S1-casein
highly phosphorylated (optimized for calcium transport). Can influence monocyte
differentiation toward macrophage phenotype and suppress dendritic cell differentiation.
Major allergen in cow''s milk allergy. Ectopic expression outside mammary gland
observed in autoimmune/inflammatory diseases and some cancers.'
existing_annotations:
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Extracellular space - in milk extracellularly.
action: ACCEPT
reason: Specific extracellular location.
supported_by:
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-openai.md
supporting_text: See deep research file for comprehensive analysis
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
supporting_text: For CSN1S1/αS1-casein, the functional location is primarily
**extracellular in milk**, where it participates in micelle formation
- term:
id: GO:0032355
label: response to estradiol
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: CSN1S1 gene expression is regulated by estradiol during mammary
gland development and lactation. Estrogen is critical for mammary
epithelial cell proliferation and differentiation.
action: KEEP_AS_NON_CORE
reason: Reflects transcriptional regulation of CSN1S1 during mammary
development rather than a direct molecular function of the protein itself.
Hormone response at gene expression level is upstream of protein function.
- term:
id: GO:0032570
label: response to progesterone
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: CSN1S1 gene expression is regulated by progesterone during mammary
gland development. Progesterone prepares mammary tissue for milk
production during pregnancy.
action: KEEP_AS_NON_CORE
reason: Reflects transcriptional regulation during mammary development
rather than direct protein function. Appropriate IBA annotation but not a
core molecular activity.
- term:
id: GO:1903494
label: response to dehydroepiandrosterone
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: DHEA is an androgen precursor with potential effects on mammary
tissue. Less direct connection to CSN1S1 than estrogen/progesterone.
action: KEEP_AS_NON_CORE
reason: Phylogenetically inferred annotation. May reflect species-specific
hormonal regulation of milk protein genes. Not a core function of the
mature CSN1S1 protein.
- term:
id: GO:1903496
label: response to 11-deoxycorticosterone
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: 11-deoxycorticosterone is a glucocorticoid precursor.
Glucocorticoids do participate in regulation of milk protein gene
expression during lactation.
action: KEEP_AS_NON_CORE
reason: Phylogenetically inferred annotation reflecting hormonal regulation
of milk protein genes. Glucocorticoids modulate lactation but this is
upstream transcriptional regulation, not protein function.
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Extracellular region - secreted into milk.
action: ACCEPT
reason: Core localization.
supported_by:
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
supporting_text: Caseins are **synthesized in the mammary gland** and proceed
through the **endoplasmic reticulum and Golgi** where they undergo
post-translational modifications; they are then **secreted into milk
as colloidal micelles**
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: Generic protein binding from HuRI interactome study. CSN1S1
self-associates and interacts with other caseins to form micelles.
action: REMOVE
reason: Uninformative generic term per curation guidelines. The biologically
relevant interactions are casein self-association and inter-casein binding
to form micellar structures, but "protein binding" does not capture this
specificity. The HuRI study is a high-throughput screen without functional
context.
supported_by:
- reference_id: PMID:32296183
supporting_text: Apr 8. A reference map of the human binary protein
interactome.
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5340124
review:
summary: Extracellular region - secreted into milk.
action: ACCEPT
reason: Core localization.
supported_by:
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
supporting_text: Caseins are **synthesized in the mammary gland** and proceed
through the **endoplasmic reticulum and Golgi** where they undergo
post-translational modifications; they are then **secreted into milk
as colloidal micelles**
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: NAS
review:
summary: alpha-S1-casein binds Ca2+ ions through clusters of phosphoserine
residues in its hydrophilic phosphopeptide region, enabling formation of
calcium-phosphate-stabilized casein micelles in milk.
action: NEW
reason: Core molecular function of caseins. Phosphoserine-clustered
Ca2+ binding is what allows alpha-S1/alpha-S2/beta-caseins to coordinate
colloidal calcium phosphate inside micelles and deliver bioavailable
mineral nutrition to the nursing infant.
supported_by:
- reference_id: file:human/CSN1S1/CSN1S1-uniprot.txt
supporting_text: Major milk phosphoprotein that binds calcium ions via
phosphoserine clusters, forming calcium-phosphate-rich micelles for
efficient mineral and protein delivery to nursing infant. Also has
immunomodul...
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
supporting_text: αS1-, αS2-, and β-caseins are calcium-binding phosphoproteins
located mainly in the micelle interior, associating with colloidal
calcium phosphate
- term:
id: GO:0007595
label: lactation
evidence_type: NAS
review:
summary: alpha-S1-casein is a major secreted milk-specific phosphoprotein
synthesized by mammary epithelial cells under prolactin/glucocorticoid
control and secreted into milk during lactation, where it co-assembles
with other caseins into colloidal micelles.
action: NEW
reason: Lactation captures the developmental/physiological process in which
CSN1S1 carries out its function; secretion into milk is the gene's
defining biological context.
supported_by:
- reference_id: file:human/CSN1S1/CSN1S1-uniprot.txt
supporting_text: Major milk phosphoprotein that binds calcium ions via
phosphoserine clusters, forming calcium-phosphate-rich micelles for
efficient mineral and protein delivery to nursing infant. Also has
immunomodul...
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
supporting_text: Caseins are **synthesized in the mammary gland** and proceed
through the **endoplasmic reticulum and Golgi** where they undergo
post-translational modifications; they are then **secreted into milk
as colloidal micelles**
- term:
id: GO:0140314
label: calcium ion sequestering activity
evidence_type: NAS
review:
summary: Alpha-S1-casein binds Ca2+ via clusters of phosphoserine residues
and traps it as colloidal calcium phosphate (CCP) inside casein micelle
interiors, removing free Ca2+ from the available pool and stabilizing
otherwise supersaturating calcium-phosphate concentrations in milk for
delivery to the nursing infant.
action: NEW
reason: |
GO:0140314 (calcium ion sequestering activity, defined as binding to a calcium ion
to prevent it from interacting with other partners or to inhibit its localization)
accurately captures the casein function. The previously proposed GO:0006816
(calcium ion transport) is inappropriate -- caseins are secreted structural
phosphoproteins, not transporters or pores. Replaces a previously proposed
GO:0006816 NEW annotation per PR #678 review feedback.
supported_by:
- reference_id: file:human/CSN1S1/CSN1S1-uniprot.txt
supporting_text: Major milk phosphoprotein that binds calcium ions via
phosphoserine clusters, forming calcium-phosphate-rich micelles for
efficient mineral and protein delivery to nursing infant.
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
supporting_text: caseins assemble with **colloidal calcium phosphate** into
casein micelles; αS1-, αS2-, and β-caseins are emphasized as
**calcium-binding** and located mainly in the micelle interior
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods.
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: Reactome:R-HSA-5340124
title: CSN polymer binds CaPO4
findings: []
- id: file:human/CSN1S1/CSN1S1-deep-research-openai.md
title: Deep research on CSN1S1 function
findings: []
- id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
title: Falcon deep research on CSN1S1 function
findings:
- statement: Human CSN1S1 encodes αS1-casein, a secreted milk phosphoprotein
that participates in casein micelle architecture and supports
nutrient/mineral delivery; in humans αS1-casein is a minor casein
component (~3% of casein) relative to β- and κ-casein, with mean human
casein micelle diameter 64–80 nm.
supporting_text: 'Primary function:** Human CSN1S1 encodes αS1-casein, a
secreted milk phosphoprotein that participates in **casein micelle**
architecture and thereby supports nutrient/mineral delivery; in humans
it is a **minor casein component** relative to β- and κ-casein'
reference_section_type: DISCUSSION
- statement: αS1-casein is a documented precursor for Casoxin D (αS1-casein
f158–164; YVPFPPF), classified in reviews as an opioid antagonist
peptide.
supporting_text: αS1-casein is a documented precursor for **Casoxin D**
(αS1-casein f158–164; **YVPFPPF**), classified in reviews as an
**opioid antagonist** peptide
reference_section_type: DISCUSSION
- id: PMID:36903269
title: 'Caseins: Versatility of Their Micellar Organization in Relation to the
Functional and Nutritional Properties of Milk'
findings:
- statement: αS1-, αS2-, and β-caseins are calcium-binding phosphoproteins
located mainly in the casein micelle interior, associating with colloidal
calcium phosphate; κ-casein forms the stabilizing surface layer.
reference_section_type: DISCUSSION
- statement: In human milk, αS1-casein is a minor casein fraction (~3% of
casein), with total casein concentration 2.4–4.2 g/L and mean micelle
diameter 64–80 nm.
reference_section_type: DISCUSSION
aliases:
- Alpha-S1-casein
- Casein alpha s1
core_functions:
- molecular_function:
id: GO:0140314
label: calcium ion sequestering activity
description: Major milk phosphoprotein that binds calcium ions via
phosphoserine clusters, sequestering them as colloidal calcium phosphate
in casein micelles for efficient mineral and protein delivery to nursing
infant. Also has immunomodulatory capacity - unphosphorylated form can
engage TLR4 on immune cells triggering cytokine release. Generates
bioactive peptides upon proteolysis.
locations:
- id: GO:0005576
label: extracellular region
directly_involved_in:
- id: GO:0007595
label: lactation
supported_by:
- reference_id: file:human/CSN1S1/CSN1S1-uniprot.txt
supporting_text: Major milk phosphoprotein that binds calcium ions via
phosphoserine clusters, forming calcium-phosphate-rich micelles for
efficient mineral and protein delivery to nursing infant. Also has
immunomodul...
- reference_id: file:human/CSN1S1/CSN1S1-deep-research-falcon.md
supporting_text: αS1-, αS2-, and β-caseins are calcium-binding phosphoproteins
located mainly in the micelle interior, associating with colloidal
calcium phosphate
status: COMPLETE